Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
02/2008
02/14/2008CA2695306A1 Genes and proteins of brachyspira hyodysenteriae and uses thereof
02/14/2008CA2661446A1 Treatment of pulmonary disease conditions
02/14/2008CA2660324A1 Plasmids with immunological action
02/14/2008CA2657517A1 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
02/13/2008EP1887084A1 Plasmids with immunological action
02/13/2008EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas
02/13/2008EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses
02/13/2008EP1886688A1 Method for producing nucleic acid-containing complex preparation
02/13/2008EP1885863A2 Methods for delivering genes
02/13/2008EP1885858A2 Treatment of disease using an improved regulated expression system
02/13/2008EP1885854A2 Methods and sequences to suppress primate huntington gene expression
02/13/2008EP1885745A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections
02/13/2008EP1885739A2 Method of inhibiting intimal hyperplasia
02/13/2008EP1885186A2 Method of targeted gene delivery using viral vectors
02/13/2008EP1578915A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
02/13/2008EP1543109B1 Substances for preventing and treating autoimmune diseases
02/13/2008EP1470148A4 Double-stranded oligonucleotides
02/13/2008EP1248646B1 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
02/13/2008EP1207200B1 High affinity choline transporter
02/13/2008EP1171617B1 Enhancement of the immune response for vaccine and gene therapy applications
02/13/2008EP1068350B1 Directed antisense libraries
02/13/2008EP0843731B1 Adenovirus vectors for gene therapy
02/13/2008EP0837928B1 Recombinant poxvirus - cytomegalovirus compositions and uses
02/13/2008EP0755454B1 Aav-mediated delivery of dna to cells of the nervous system
02/13/2008CN101124328A Chimeric vectors
02/13/2008CN101124327A Modified CEA/B7 vector
02/13/2008CN101124237A Surface proteins of streptococcus pyogenes
02/13/2008CN101123994A Therapeutic uses of inhibitors of rtp801
02/13/2008CN101123993A Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
02/13/2008CN101123972A Methods for protein production
02/13/2008CN101121933A SiRNA used for kinase gene overexpression related disease
02/13/2008CN101121023A Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases
02/13/2008CN101120921A Target preparation consisting of liposome and nucleic acid coating contrast agent
02/13/2008CN100368550C High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
02/13/2008CN100368547C Factors affecting tumor necrosis factor receptor releasing enzyme activity
02/13/2008CN100368438C Anti-hepatitis B virus fusion protein and its coding gene and application
02/13/2008CN100368424C Tumor inhibiting antisense nucleotide
02/13/2008CN100368018C Fumor invasion and metastasis resisting function and use of venin cysteine proteinase inhibitor
02/12/2008US7329741 G proteins; antiproliferative agents; gene therapy
02/12/2008US7329731 Soluble T cell receptor
02/12/2008US7329728 Ligand activated transcriptional regulator proteins
02/12/2008US7329649 Combinatorial methods for inducing cancer cell death
02/12/2008US7329648 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
02/12/2008US7329541 Zinc finger binding domains for GNN
02/12/2008US7329510 Containing specific DNA sequence; use in the therapy of disorders selected from human psychiatric and neurological disroders, cardiiovascular disorder, and reproductive dysfunction
02/12/2008US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes
02/12/2008US7329415 Bulking composite comprising liposomes stabilized by a shell of polyelectrolytes, with charging surface and opposite charging on underlayer; for use in biomedical drug delivery, in vivo detectors, and gene therapy, ophthalmic lens
02/12/2008US7329408 Eliciting HCV-specific antibodies
02/12/2008CA2203246C Alk-7 (activin like kinase), a serine threonine kinase receptor
02/12/2008CA2133982C Ligand for the c-kit receptor and methods of use thereof
02/12/2008CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics
02/07/2008WO2008016958A2 Reproductive cell media compositions and methods for improving fertility
02/07/2008WO2008016924A2 Identification of a micro-rna that activates expression of beta-myosin heavy chain
02/07/2008WO2008016919A2 Mastopexy and breast reconstruction prostheses and method
02/07/2008WO2008016673A2 Bioactive scaffolds
02/07/2008WO2008016490A2 Modified two-component gelation systems for the treatment of post-myocardial infarction
02/07/2008WO2008016141A1 Kif-derived peptide capable of binding to hla-a24 molecule
02/07/2008WO2008015942A1 Therapeutic agent for neuroblastoma, method for screening for the therapeutic agent, and method for determination of prognosis of neuroblastoma
02/07/2008WO2008015841A1 Kinase-inhibiting fused protein and pharmaceutical composition
02/07/2008WO2008015675A2 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
02/07/2008WO2008015383A2 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies
02/07/2008WO2008015028A1 Uses and compositions comprising mirnas
02/07/2008WO2008014668A1 Attenuated salmonella carrying effective plasmid and its antitumorigenic use
02/07/2008WO2008014612A1 Fusion proteins and methods for modulation of immune response
02/07/2008WO2008014603A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
02/07/2008US20080033156 Short interfering nucleic acid (siNA) molecule and a polyamine compound having guanidinium, amine, or histidyl end groups and optionally containing polyether groups; biodrug delivery
02/07/2008US20080032945 2'-modified oligonucleotides
02/07/2008US20080032943 Using concentration of cancer-associated gene products as diagnostic tool in detection of thyroid cell proliferative disorders
02/07/2008US20080032941 Method for rendering a system immunologically compatible utilizing a nucleic acid construct, a nucleic acid construct for inhibiting or regulating the function of an immune response (Ir) gene and an immunologically compatible system containing a nucleic acid construct for inhibiting or regulating the function of an immune response (Ir) gene
02/07/2008US20080032926 Knockout Non-Human Animal
02/07/2008US20080032918 Gene expression or biosynthesis inhibition by locally administering inhibitors of angiotensin-converting enzyme, angiotensin type 1 receptors, or sodium-hydrogen exchange type-1 proteins; antiinflammatory agents, myocardial antiischemic agents, anaphylaxis; sustained release implants, stents, inhalers
02/07/2008US20080032337 Genetic engineering; analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases
02/07/2008US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor
02/07/2008US20080032283 Telomelysin/gfp-expressing recombinant virus
02/07/2008US20080032279 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
02/07/2008US20080031936 Immunostimulatory nucleic acid molecules
02/07/2008US20080031915 Cartilage and Bone Repair Composition
02/07/2008US20080031911 Inhibiting smad signaling promotes neuron regeneration
02/07/2008US20080031886 Viruses for the treatment of cellular proliferative disorders
02/07/2008US20080031880 Use of ErbB receptor ligands in treating diabetes
02/07/2008US20080031819 Compositions and Methods that Enhance Articular Cartilage Repair
02/07/2008US20080030713 Uncaging devices
02/07/2008DE19900284B4 Verfahren zum effizienten Einschleusen von DNA in Eukaryontenzellen unter Verwendung eines adenoviralen Vektors A method for efficiently introducing DNA into eukaryotic cells using an adenoviral vector
02/07/2008DE102006035618A1 New nucleic acid useful as immuno-stimulating adjuvant for manufacture of a composition for treatment of cancer diseases e.g. colon carcinomas and infectious diseases e.g. influenza and malaria
02/07/2008DE102004034461B4 Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren Gene therapy of solid tumors by retroviral, with arena virus glycoprotein pseudotyped vectors
02/07/2008CA2693326A1 Gm-csf and il-15 fusokines and methods for modulation of the immune response
02/07/2008CA2659364A1 Identification of a micro-rna that activates expression of .beta.-myosin heavy chain
02/07/2008CA2658972A1 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
02/06/2008EP1884570A1 Gene transfer method
02/06/2008EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation
02/06/2008EP1884232A1 Method of producing liposomes containing gas enclosed therein
02/06/2008EP1883709A2 Human micrornas and methods for inhibiting same
02/06/2008EP1883708A1 Genemap of the human genes associated with crohn's disease
02/06/2008EP1883699A2 Non-viral vector system for transporting nucleic acid into the lungs
02/06/2008EP1883427A2 Compositions and methods for studying and treating inflammatory diseases and disorders
02/06/2008EP1697515A4 Dna-carrier conjugate
02/06/2008EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation
02/06/2008CN101120099A Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna
02/06/2008CN101120086A Flavivirus replicon constructs for tumour therapy
02/06/2008CN101117644A Diagnostics and therapeutics for glaucoma